T-cell lymphoma of the oral cavity: a case report.

Lymphomas are defined as heterogeneous malignancies of the lymphatic system characterized by a proliferation of lymphoid cells or their precursors. Malignant lymphoma of the oral cavity has been described previously although reports on the occurrence of intraoral extranodal T-cell lymphomas are scarce. Oral lesions may appear as a painless enlargement, erythematous, often with surface ulceration secondary to trauma. This is a report of a rare case in which a specific subtype of T-cell lymphoma appeared in the oral cavity.

[1]  J. Shibli,et al.  Gingival primary extranodal non-Hodgkin's lymphoma as the first manifestation of acquired immunodeficiency syndrome. , 2008, Journal of periodontology.

[2]  G. Ellis.  Lymphoid lesions of salivary glands: malignant and benign. , 2007, Medicina oral, patologia oral y cirugia bucal.

[3]  E. Engels.  Infectious Agents as Causes of Non-Hodgkin Lymphoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[4]  B. Hancock,et al.  Non-Hodgkin lymphoma , 2003, The Lancet.

[5]  J. Epstein,et al.  Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases. , 2001, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[6]  H. Prince,et al.  Primary large-cell non-Hodgkin's lymphoma of the testis: a retrospective analysis of patterns of failure and prognostic factors. , 2001, Clinical lymphoma.

[7]  C. Scully,et al.  Oral mucosal non-Hodgkin's lymphoma--a dangerous mimic. , 2000, Oral oncology.

[8]  G Flandrin,et al.  The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  G. Salles,et al.  Profiles and prognostic values of LDH isoenzymes in patients with non-Hodgkin’s lymphoma , 1999, Leukemia.

[10]  P. Slootweg,et al.  Primary extranodal CD30-positive T-cell non-Hodgkin's lymphoma of the oral mucosa , 1996 .

[11]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[12]  Rosenberg Sa.  Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas. , 1977 .

[13]  N. Treister,et al.  Medical management update: Non-Hodgkin lymphoma. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.